Published online before print October 27, 2003, doi: 10.1161/01.CIR.0000099542.57313.C5
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:2460.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
Human Epicardial Adipose Tissue Is a Source of Inflammatory Mediators
From the Departments of Surgery (T.M., L.Z., J.D.M., J.T.D., H.A., Y.S.) and Medicine (A.Z., B.J.G.), Thomas Jefferson University, Philadelphia, Pa; GlaxoSmithKline (A.Z., L.S.-B., S.O., E.A.K., A.G.J.), King of Prussia, Pa; and Bryn Mawr Hospital (J.M.), Bryn Mawr, Pa.
Correspondence to Yi Shi, MD, PhD, Department of Surgery, Thomas Jefferson University, Suite 623, 1025 Walnut St, Philadelphia, PA 19107 (e-mail yi.shi{at}jefferson.edu), or Andrew Zalewski, MD, GlaxoSmithKline, King of Prussia, PA 19406 (e-mail andrew.2.zalewski@gsk.com).
Received August 19, 2003; revision received September 10, 2003; accepted September 17, 2003.
Background— Inflammatory mediators that originate in vascular and extravascular tissues promote coronary lesion formation. Adipose tissue may function as an endocrine organ that contributes to an inflammatory burden in patients at risk of cardiovascular complications. In this study, we sought to compare expression of inflammatory mediators in epicardial and subcutaneous adipose stores in patients with critical CAD.
Methods and Results— Paired samples of epicardial and subcutaneous adipose tissues were harvested at the outset of elective CABG surgery (n=42; age 65±10 years). Local expression of chemokine (monocyte chemotactic protein [MCP]-1) and inflammatory cytokines (interleukin [IL]-1ß, IL-6, and tumor necrosis factor [TNF]-
) was analyzed by TaqMan real-time reverse transcription–polymerase chain reaction (mRNA) and by ELISA (protein release over 3 hours). Significantly higher levels of IL-1ß, IL-6, MCP-1, and TNF- mRNA and protein were observed in epicardial adipose stores. Proinflammatory properties of epicardial adipose tissue were noted irrespective of clinical variables (diabetes, body mass index, and chronic use of statins or ACE inhibitors/angiotensin II receptor blockers) or plasma concentrations of circulating biomarkers. In a subset of samples (n=11), global gene expression was explored by DNA microarray hybridization and confirmed the presence of a broad inflammatory reaction in epicardial adipose tissue in patients with coronary artery disease. The above findings were paralleled by the presence of inflammatory cell infiltrates in epicardial adipose stores.
Conclusions— Epicardial adipose tissue is a source of several inflammatory mediators in high-risk cardiac patients. Plasma inflammatory biomarkers may not adequately reflect local tissue inflammation. Current therapies do not appear to eliminate local inflammatory signals in epicardial adipose tissue.
Key Words: inflammation • atherosclerosis • coronary disease
This article has been cited by other articles:
 |
|
 |
|
  A. M. de Vos, M. Prokop, C. J. Roos, M. F.L. Meijs, Y. T. van der Schouw, A. Rutten, P. M. Gorter, M.-J. Cramer, P. A. Doevendans, B. J. Rensing, et al. Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women Eur. Heart J., March 2, 2008; 29(6): 777 - 783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Chaowalit and F. Lopez-Jimenez Epicardial adipose tissue: friendly companion or hazardous neighbour for adjacent coronary arteries? Eur. Heart J., March 2, 2008; 29(6): 695 - 697. [Full Text] [PDF]
|
|
|
|
 |
|
 S-G Ahn, H-S Lim, D-Y Joe, S-J Kang, B-J Choi, S-Y Choi, M-H Yoon, G-S Hwang, S-J Tahk, and J-H Shin Relationship of epicardial adipose tissue by echocardiography to coronary artery disease Heart, March 1, 2008; 94(3): e7 - e7. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Rosito, J. M. Massaro, U. Hoffmann, F. L. Ruberg, A. A. Mahabadi, R. S. Vasan, C. J. O'Donnell, and C. S. Fox Pericardial Fat, Visceral Abdominal Fat, Cardiovascular Disease Risk Factors, and Vascular Calcification in a Community-Based Sample: The Framingham Heart Study Circulation, February 5, 2008; 117(5): 605 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Sironi, A. Pingitore, S. Ghione, D. De Marchi, B. Scattini, V. Positano, E. Muscelli, D. Ciociaro, M. Lombardi, E. Ferrannini, et al. Early Hypertension Is Associated With Reduced Regional Cardiac Function, Insulin Resistance, Epicardial, and Visceral Fat Hypertension, February 1, 2008; 51(2): 282 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. S. Vlachos, A. Hatziioannou, A. Perelas, and D. N. Perrea Sonographic Assessment of Regional Adiposity Am. J. Roentgenol., December 1, 2007; 189(6): 1545 - 1553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Gruen, M. Hao, D. W. Piston, and A. H. Hasty Leptin requires canonical migratory signaling pathways for induction of monocyte and macrophage chemotaxis Am J Physiol Cell Physiol, November 1, 2007; 293(5): C1481 - C1488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Silaghi, V. Achard, O. Paulmyer-Lacroix, T. Scridon, V. Tassistro, I. Duncea, K. Clement, A. Dutour, and M. Grino Expression of adrenomedullin in human epicardial adipose tissue: role of coronary status Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1443 - E1450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. PEPE Dietary Polyunsaturated Fatty Acids and Age-Related Membrane Changes in the Heart Ann. N.Y. Acad. Sci., October 1, 2007; 1114(1): 381 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Chaowalit, V. K. Somers, P. A. Pellikka, C. S. Rihal, and F. Lopez-Jimenez Adipose Tissue of Atrial Septum as a Marker of Coronary Artery Disease Chest, September 1, 2007; 132(3): 817 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Haurani and P. J. Pagano Adventitial fibroblast reactive oxygen species as autacrine and paracrine mediators of remodeling: Bellwether for vascular disease? Cardiovasc Res, September 1, 2007; 75(4): 679 - 689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Thalmann and C. A. Meier Local adipose tissue depots as cardiovascular risk factors Cardiovasc Res, September 1, 2007; 75(4): 690 - 701. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Matter and C. Handschin RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted), Inflammation, Obesity, and the Metabolic Syndrome Circulation, February 27, 2007; 115(8): 946 - 948. [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Mazzadi, X. Andre-Fouet, N. Costes, P. Croisille, D. Revel, and M. F. Janier Mechanisms leading to reversible mechanical dysfunction in severe CAD: alternatives to myocardial stunning Am J Physiol Heart Circ Physiol, December 1, 2006; 291(6): H2570 - H2582. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kremen, M. Dolinkova, J. Krajickova, J. Blaha, K. Anderlova, Z. Lacinova, D. Haluzikova, L. Bosanska, M. Vokurka, S. Svacina, et al. Increased Subcutaneous and Epicardial Adipose Tissue Production of Proinflammatory Cytokines in Cardiac Surgery Patients: Possible Role in Postoperative Insulin Resistance J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4620 - 4627. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Herder, J. Baumert, B. Thorand, S. Martin, H. Lowel, H. Kolb, and W. Koenig Chemokines and Incident Coronary Heart Disease: Results From the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002 Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2147 - 2152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sell, D. Dietze-Schroeder, U. Kaiser, and J. Eckel Monocyte Chemotactic Protein-1 Is a Potential Player in the Negative Cross-Talk between Adipose Tissue and Skeletal Muscle Endocrinology, May 1, 2006; 147(5): 2458 - 2467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E Malavazos, E. Cereda, L. Morricone, C. Coman, M. M Corsi, and B. Ambrosi Monocyte chemoattractant protein 1: a possible link between visceral adipose tissue-associated inflammation and subclinical echocardiographic abnormalities in uncomplicated obesity Eur. J. Endocrinol., December 1, 2005; 153(6): 871 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Henrichot, C. E. Juge-Aubry, A. Pernin, J.-C. Pache, V. Velebit, J.-M. Dayer, P. Meda, C. Chizzolini, and C. A. Meier Production of Chemokines by Perivascular Adipose Tissue: A Role in the Pathogenesis of Atherosclerosis? Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2594 - 2599. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Iacobellis and F. Leonetti Epicardial Adipose Tissue and Insulin Resistance in Obese Subjects J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6300 - 6302. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Engeli Is there a pathophysiological role for perivascular adipocytes? Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1794 - H1795. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Dietze-Schroeder, H. Sell, M. Uhlig, M. Koenen, and J. Eckel Autocrine Action of Adiponectin on Human Fat Cells Prevents the Release of Insulin Resistance-Inducing Factors Diabetes, July 1, 2005; 54(7): 2003 - 2011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Noronha, J.-M. Li, S. B. Wheatcroft, A. M. Shah, and M. T. Kearney Inducible Nitric Oxide Synthase Has Divergent Effects on Vascular and Metabolic Function in Obesity Diabetes, April 1, 2005; 54(4): 1082 - 1089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Axelsson, A. Rashid Qureshi, M. E Suliman, H. Honda, R. Pecoits-Filho, O. Heimburger, B. Lindholm, T. Cederholm, and P. Stenvinkel Truncal fat mass as a contributor to inflammation in end-stage renal disease Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1222 - 1229. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. H. Gibbons, C. C. Liew, M. O. Goodarzi, J. I. Rotter, W. A. Hsueh, H. M. Siragy, R. Pratt, and V. J. Dzau Genetic Markers: Progress and Potential for Cardiovascular Disease Circulation, June 29, 2004; 109(25_suppl_1): IV-47 - IV-58. [Full Text] [PDF]
|
|